HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
120,63
EUR
-6,92
EUR
-5,43
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 6,12% |
| Amgen Inc | US0311621009 | 6,08% |
| Gilead Sciences Inc | US3755581036 | 4,75% |
| Zealand Pharma AS | DK0060257814 | 4,58% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,39% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,97% |
| Biohaven Ltd | VGG1110E1079 | 3,77% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,63% |
| UCB SA | BE0003739530 | 3,40% |
| AstraZeneca PLC ADR | US0463531089 | 2,94% |
| Sonstige | 56,35% |